A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients with Heparin Resistance †
Mirjam Bachler(Innsbruck Medical University), D Friès(Innsbruck Medical University), Bettina Schenk(Apple (Israel)), Elgar Oswald(Universität Innsbruck), Bernd Wallner(Innsbruck Medical University), Mathias Ströhle(University of Applied Sciences Kufstein), Benjamin Treichl(Apple (Israel)), Christian Irsara(Innsbruck Medical University), Benedikt Treml(Innsbruck Medical University), Ingo Lorenz(Universität Innsbruck), Daniel Stengg(Innsbruck Medical University), Stefan Hruby(Innsbruck Medical University), Barbara Friesenecker(Innsbruck Medical University), Christian Niederwanger(Apple (Israel)), Johannes Bösch(Innsbruck Medical University), Tobias Hell(Universität Innsbruck)
Cited by 18
Related Papers
Causes of death and determinants of outcome in critically ill patients
|Critical Care|2006|253
The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS
|Journal of Breath Research|2008|152
Impaired fibrinolysis in critically ill COVID-19 patients
|British Journal of Anaesthesia|2020|117